ProMIS Neurosciences (PMN) Income towards Parent Company (2021 - 2026)

ProMIS Neurosciences (PMN) has 6 years of Income towards Parent Company data on file, last reported at -$8.7 million in Q1 2026.

• Quarterly Income towards Parent Company fell 16.84% year-over-year to -$8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$82.5 million (down 298.5% YoY) and the FY2025 annual result came in at -$81.2 million, down 66.71% from the prior year.
• Income towards Parent Company grew to -$8.7 million in Q1 2026, from -$51.8 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of -$2.6 million in Q3 2023 to a low of -$51.8 million in Q4 2025.
• A 5-year average of -$8.5 million and a median of -$5.0 million in 2022 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2023 — Income towards Parent Company soared 57.2% — and 2025, when it slumped 763.16%.
• Tracing PMN's Income towards Parent Company over 5 years: stood at -$8.5 million in 2022, then surged by 53.64% to -$4.0 million in 2023, then slumped by 51.91% to -$6.0 million in 2024, then tumbled by 763.16% to -$51.8 million in 2025, then jumped by 83.18% to -$8.7 million in 2026.
• The last three Income towards Parent Company figures came in at -$8.7 million (Q1 2026), -$51.8 million (Q4 2025), and -$11.8 million (Q3 2025), per Business Quant data.